206 related articles for article (PubMed ID: 36222741)
1. Rapid eye movement sleep duration during the multiple sleep latency test to diagnose hypocretin-deficient narcolepsy.
Lopez R; Barateau L; Laura Rassu A; Evangelista E; Chenini S; Scholz S; Jaussent I; Dauvilliers Y
Sleep; 2023 Jan; 46(1):. PubMed ID: 36222741
[TBL] [Abstract][Full Text] [Related]
2. Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.
Andlauer O; Moore H; Jouhier L; Drake C; Peppard PE; Han F; Hong SC; Poli F; Plazzi G; O'Hara R; Haffen E; Roth T; Young T; Mignot E
JAMA Neurol; 2013 Jul; 70(7):891-902. PubMed ID: 23649748
[TBL] [Abstract][Full Text] [Related]
3. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Clinical Correlates of a Short Onset REM Period (SOREMP) during Routine PSG.
Cairns A; Bogan R
Sleep; 2015 Oct; 38(10):1575-81. PubMed ID: 26039966
[TBL] [Abstract][Full Text] [Related]
5. Optimizing MSLT Specificity in Narcolepsy With Cataplexy.
Murer T; Imbach LL; Hackius M; Taddei RN; Werth E; Poryazova R; Gavrilov YV; Winkler S; Waldvogel D; Baumann CR; Valko PO
Sleep; 2017 Dec; 40(12):. PubMed ID: 29069490
[TBL] [Abstract][Full Text] [Related]
6. Repeated polysomnography and multiple sleep latency test in narcolepsy type 1 and other hypersomnolence disorders.
Torstensen EW; Haubjerg Østerby NC; Kornum BR; Wanscher B; Mignot E; Barløse M; Jennum PJ
Sleep Med; 2023 Oct; 110():91-98. PubMed ID: 37544279
[TBL] [Abstract][Full Text] [Related]
7. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.
Marti I; Valko PO; Khatami R; Bassetti CL; Baumann CR
Sleep Med; 2009 Dec; 10(10):1146-50. PubMed ID: 19464232
[TBL] [Abstract][Full Text] [Related]
8. Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1.
van der Hoeven AE; Fronczek R; Schinkelshoek MS; Roelandse FWC; Bakker JA; Overeem S; Bijlenga D; Lammers GJ
Sleep; 2022 May; 45(5):. PubMed ID: 35554594
[TBL] [Abstract][Full Text] [Related]
9. The REM-sleep-related characteristics of narcolepsy: a nation-wide multicenter study in Turkey, the REMCON study.
Akyildiz UO; Tezer FI; Koc G; Ismailogullari S; Demir AB; Ak AK; Sunter G; Kara KA; Berktas DT; Sahin A; Azman F; Akcay BD; Gok DK; Yilmaz H; Agan K; Bekmezci Y; Yetkin S; Aksu M; Karadeniz D; Senel GB
Sleep Med; 2022 Jun; 94():17-25. PubMed ID: 35447401
[TBL] [Abstract][Full Text] [Related]
10. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality.
Ruoff C; Rye D
Curr Med Res Opin; 2016 Oct; 32(10):1611-1622. PubMed ID: 27359185
[TBL] [Abstract][Full Text] [Related]
11. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness.
Hong SC; Lin L; Jeong JH; Shin YK; Han JH; Lee JH; Lee SP; Zhang J; Einen M; Mignot E
Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989
[TBL] [Abstract][Full Text] [Related]
12. Nocturnal Sleep Dynamics Identify Narcolepsy Type 1.
Pizza F; Vandi S; Iloti M; Franceschini C; Liguori R; Mignot E; Plazzi G
Sleep; 2015 Aug; 38(8):1277-84. PubMed ID: 25845690
[TBL] [Abstract][Full Text] [Related]
13. Multiple sleep latency test and polysomnography in patients with central disorders of hypersomnolence.
Dietmann A; Gallino C; Wenz E; Mathis J; Bassetti CLA
Sleep Med; 2021 Mar; 79():6-10. PubMed ID: 33453460
[TBL] [Abstract][Full Text] [Related]
14. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
Baumann CR; Khatami R; Werth E; Bassetti CL
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
[TBL] [Abstract][Full Text] [Related]
15. Validation of Multiple Sleep Latency Test for the diagnosis of pediatric narcolepsy type 1.
Pizza F; Barateau L; Jaussent I; Vandi S; Antelmi E; Mignot E; Dauvilliers Y; Plazzi G;
Neurology; 2019 Sep; 93(11):e1034-e1044. PubMed ID: 31405906
[TBL] [Abstract][Full Text] [Related]
16. What Does One Sleep-Onset REM Period—During Either Nocturnal Polysomnography or Multiple Sleep Latency Test—Mean in Differential Diagnosis of Central Hypersomnias?
Bozluolcay M; Nalbantoglu M; Benbir Senel G; Karadeniz D
J Clin Neurophysiol; 2015 Aug; 32(4):364-8. PubMed ID: 26241245
[TBL] [Abstract][Full Text] [Related]
17. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
[TBL] [Abstract][Full Text] [Related]
18. Clinical and neurophysiological characteristics of 89 patients with narcolepsy and cataplexy from the Russian Narcolepsy Network.
Kuts A; Poluektov M; Zakharov A; Govzman V; Ponomareva I; Yakupov E; Zavalko I; Tikhomirova O; Sviryaev Y; Yakovlev A; Polyakov A; Melnikov A; Bassetti CLA
J Clin Sleep Med; 2023 Feb; 19(2):355-359. PubMed ID: 36305577
[TBL] [Abstract][Full Text] [Related]
19. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
[TBL] [Abstract][Full Text] [Related]
20. Presentations of primary hypersomnia in Chinese children.
Han F; Lin L; Li J; Aran A; Dong SX; An P; Zhao L; Li M; Li QY; Yan H; Wang JS; Gao HY; Li M; Gao ZC; Strohl KP; Mignot E
Sleep; 2011 May; 34(5):627-32. PubMed ID: 21532956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
